Breast Cancer News and Research

Latest Breast Cancer News and Research

Breast brachytherapy with strut-based applicator effective for women with DCIS

Breast brachytherapy with a strut-based applicator appears to be an effective treatment for women who have ductal carcinoma in situ (DCIS) of the breast, according to a groundbreaking study presented at the annual meeting of the American Society of Breast Surgeons, held in Phoenix May 2-4.

8 May 2012

iCAD first quarter total revenue decreases 14% to $6.3 million

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for the first quarter ended March 31, 2012.

8 May 2012

Breast cancer in men rarer but more deadly than in women

“Men with breast cancer don't do as well as women with breast cancer, and there are opportunities to improve that,” said study author Dr. Jon Greif, a breast surgeon in San Francisco. “They were less likely to get the standard treatments that women get.” Survival rates for men with breast cancer, overall, are lower than those for women, at least when it is diagnosed in the early stages, Greif found. The cancers differ in other respects too.

8 May 2012

Many unaware that persistent cough could be a warning for lung cancer

Most people are aware that that a lump in the breast is a warning sign of breast cancer and bleeding could indicate bowel, kidney or bladder cancer. However, only one in ten people knows that a persistent cough could point to lung cancer.

8 May 2012

Halozyme first quarter net loss increases to $15.1 million

Halozyme Therapeutics, Inc. today reported financial results for the quarter ended March 31, 2012.

8 May 2012

Hologic features minimally invasive technologies at ACOG annual clinical meeting

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, is featuring minimally invasive technologies in surgical, diagnostic and skeletal health at The American College of Obstetricians and Gynecologists (ACOG) annual clinical meeting.

From Hologic, Inc. 7 May 2012

Ventana granted FDA clearance for Companion Algorithm p53 (DO-7) image analysis application

Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VENTANA Companion Algorithm p53 (DO-7) image analysis application using the VENTANA iScan Coreo Au scanner and VIRTUOSO software.

7 May 2012

Interdisciplinary treatment of breast cancer benefits most patients

How successful is the interdisciplinary treatment of breast cancer? Since 2003, the Breast Center at Heidelberg University Hospital has systematically tracked the course of breast cancer in more than 3,000 patients and, as the first center in Germany, has published these significant prospective results: Eighty-six percent of the patients survived the first five years after onset of treatment, with 80 % of them remaining disease-free during this period.

7 May 2012

Radiofrequency ablation during breast cancer surgery can provide effective alternative to XRT

Radiofrequency ablation of the lumpectomy site during breast cancer surgery can provide an effective alternative to post-operative external radiation therapy (XRT) and reduce repeat surgeries to achieve clear tumor margins, according to one of the first published long-term studies to examine this new treatment protocol.

5 May 2012

iCAD, Breastlink announce agreement to offer Xoft brachytherapy system

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, and Breastlink Medical Group in Southern California, today announced an agreement that will make the Xoft Axxent Electronic Brachytherapy System available to breast cancer patients treated at Breastlink.

5 May 2012

ACR names WDI as Breast Imaging Center of Excellence

Women's Digital Imaging of Ridgewood (WDI) has been named a Breast Imaging Center of Excellence by the American College of Radiology (ACR). The Center of Excellence designation is awarded to facilities that meet the highest standards set by the ACR through peer-review evaluations conducted in each breast imaging modality by board-certified physicians and medical physicists.

5 May 2012

MicroRNAs in breast cancer play a role in development of resistance to tamoxifen

Many breast cancer patients are treated with a drug called tamoxifen. The substance blocks the effect of estrogen and thus suppresses the growth signals of this hormone in cancer cells. When resistance to the drug develops, tumor cells change their growth program: They change their behavior and shape, become more mobile and also adopt the ability to invade surrounding tissue. Scientists working with PD (Associate Professor) Dr. Stefan Wiemann of the German Cancer Research Center (DKFZ) have now also observed these changes in tamoxifen resistant breast cancer cells.

5 May 2012

New light on many biological differences between individual breast cancers

New findings presented at Europe's leading breast cancer translational research conference this year shed new light on the many biological differences between individual breast cancers.

4 May 2012

Presence of fetal cells is a double-edged sword for women

For the first time, scientists have found what could be a causative link between the concentration of circulating Y-chromosome fetal cells in women who gave birth to children of either sex and their risk of later developing breast cancer and colon cancer.

4 May 2012

Potential breast cancer patients for new immune-targeting therapies

Breast cancer patients whose tumors express high levels of genes related to immune response are more likely to have their tumor completely eradicated by pre-operative chemotherapy compared to patients with low expression of these genes, Belgian researchers report at the 4th IMPAKT Breast Cancer Conference in Brussels, Belgium.

4 May 2012

New analysis may help identify breast cancer patients who will benefit from immune suppressant

A new analysis may help doctors identify breast cancer patients who will benefit from treatment with the immune suppressant drug everolimus, say French researchers at the 4th IMPAKT Breast Cancer Conference in Brussels, Belgium.

4 May 2012

Many women diagnosed with breast cancer report no family history

More than half the women aged 40-49 diagnosed with breast cancer on screening mammography report no family history, a new study shows.

4 May 2012

Positive ultrasound-guided axillary node biopsy requires dissection

Contrary to a trend in treatment, breast cancer patients with suspicious lymph nodes should have an ultrasound-guided axillary node biopsy, and if that biopsy is positive these patients should undergo an axillary dissection, a new study shows.

4 May 2012

Generon commences F-627 Phase II trial in breast cancer

Generon Corporation Ltd. today announced the initiation of a Phase II clinical trial for F-627 after US FDA regulatory clearance. The current study is a Phase II, randomized, multicenter, open-label, active-controlled trial of F-627 in women with breast cancer receiving myelotoxic chemotherapy.

4 May 2012

Potential ways for doctors to improve hormone receptor-positive breast cancer treatment

American and Spanish researchers have found potential ways for doctors to improve the treatment of hormone receptor-positive breast cancer even if they lack access to costly multi-gene tests, as they report at the 4th IMPAKT Breast Cancer Conference.

4 May 2012

Breast Cancer News and Research

Latest Breast Cancer News and Research

Breast brachytherapy with strut-based applicator effective for women with DCIS

iCAD first quarter total revenue decreases 14% to $6.3 million

Breast cancer in men rarer but more deadly than in women

Many unaware that persistent cough could be a warning for lung cancer

Halozyme first quarter net loss increases to $15.1 million

Hologic features minimally invasive technologies at ACOG annual clinical meeting

Ventana granted FDA clearance for Companion Algorithm p53 (DO-7) image analysis application

Interdisciplinary treatment of breast cancer benefits most patients

Radiofrequency ablation during breast cancer surgery can provide effective alternative to XRT

iCAD, Breastlink announce agreement to offer Xoft brachytherapy system

ACR names WDI as Breast Imaging Center of Excellence

MicroRNAs in breast cancer play a role in development of resistance to tamoxifen

New light on many biological differences between individual breast cancers

Presence of fetal cells is a double-edged sword for women

Potential breast cancer patients for new immune-targeting therapies

New analysis may help identify breast cancer patients who will benefit from immune suppressant

Many women diagnosed with breast cancer report no family history

Positive ultrasound-guided axillary node biopsy requires dissection

Generon commences F-627 Phase II trial in breast cancer

Potential ways for doctors to improve hormone receptor-positive breast cancer treatment

Industry Focus eBook - Oncology (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Breast Cancer News and Research

Latest Breast Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in